In cancer patients with sarcopenia, a decreased expression of a contractile smooth muscle marker called smoothelin and the accumulation of collagen around the intestinal plexus are both known to occur, thus resulting in an impairment of both the intestinal smooth muscle contractile function and its regulation [30]. Here, SMTN is linked to sarcopenia.